SABBY MANAGEMENT, LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 26 filers reported holding SEELOS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,169,886
+771.4%
11,792,861
+2221.4%
1.59%
+1441.7%
Q1 2020$249,000
-44.8%
508,000
+3.4%
0.10%
-57.6%
Q3 2019$451,000491,2370.24%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 508,000$249,0000.10%
1492 Capital Management LLC 150,000$74,0000.09%
Uniplan Investment Counsel, Inc. 2,069,121$1,014,0000.08%
ARDSLEY ADVISORY PARTNERS LP 70,000$34,0000.01%
Spark Investment Management LLC 35,210$17,0000.01%
TOCQUEVILLE ASSET MANAGEMENT L.P. 191,000$94,0000.00%
WealthPLAN Partners, LLC 20,000$15,0000.00%
Procyon Advisors, LLC 2,500$1,0000.00%
Renaissance Technologies 1,078,379$529,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SEELOS THERAPEUTICS INC shareholders